National business news in brief | Treasury rates edge up; Vioxx arguments
Rates edge up The Treasury Department auctioned $30 billion in three-month bills on Monday at a discount rate of 0.060 percent, up from 0.040 percent last week. Another $31 billion in six-month bills was auctioned at a discount rate of 0.150 percent, up from 0.140 percent last week. Separately, the Federal Reserve said that the average yield for one-year Treasury bills fell to 0.27 percent last
More…
Merck Buys Two Research Companies for $500 million
May 10, 2006 | The acquisitions of GlycoFi, based in Lebanon, N.H., and Abmaxis, based in Santa Clara, Calif., are both expected to close by the end of June. The purchase announcements came two weeks after the company's chief executive, Richard T. Clark, promised shareholders big changes to Merck, which has been wounded... more...
Summary: Merck wins latest Vioxx trial
THE OUTCOME: Drugmaker Merck & Co. won the latest Vioxx trial when an Atlantic City jury ruled Merck's withdrawn painkiller Vioxx was not a major cause of 68-year-old Elaine Doherty's heart attack in January 2004.
More...
Marketing of Vioxx: How Merck Played Game of Catch-Up (Herald Tribune)
At times, it is necessary to "neutralize" the opposition, or at least Merck & Company executives seemed to think so. In 1999, the company's new pain drug, Vioxx, was beaten to pharmacy shelves by a competing drug, Celebrex.
Click here for more info.